Grail

Grail ROA

The Return on Assets (ROA) of Grail (GRAL) as of Oct 18, 2026 is -13.97 %. In the previous year, Return on Assets (ROA) was -67.94 % — a change of -79.43% (higher).

ROA

-13.97 %

YoY

-79.43%

Last updated:

In 2025, Grail's return on assets (ROA) was -13.97 %, a -79.43% increase from the -67.94 % ROA in the previous year.

The Grail ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-40.14 USD
Jan 1, 2019
-38.53 USD
Jan 1, 2020
-44.20 USD
Jan 1, 2021
-12.81 USD
Jan 1, 2022
-96.38 USD
Jan 1, 2023
-32.16 USD
Jan 1, 2024
-67.94 USD
Jan 1, 2025
-13.97 USD
The Grail ROA history
YEARROAYoY
-13.97 %-79.43%
-67.94 %+111.25%
-32.16 %-66.63%
-96.38 %+652.14%
-12.81 %-71.01%
-44.20 %+14.71%
-38.53 %-4.02%
-40.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Grail Stock analysis

What does Grail do? Grail Inc, with ticker GRAL and ISIN US3847471014, is a US-based biotechnology company headquartered in Menlo Park. The company operates within the Health Care sector and has 910 employees. Grail Inc. went public on June 12, 2024. The company's website is https://www.galleri.com/. Grail Inc. focuses on early cancer detection through advanced technologies including next-generation sequencing, population-scale clinical studies, and machine learning. Its platform utilizes methylation-based approaches to support cancer screening and precision oncology, targeting multiple cancer types for early detection. The company's products include Galleri, a screening test for multi-cancer early detection, which helps guide healthcare decisions for cancer diagnosis. Grail Inc. aims to shift paradigms in cancer detection by identifying diseases at earlier stages, thereby alleviating the global burden of cancer. The company's approach integrates software, automation, and data analysis to enhance the continuum of care for cancer patients. Grail Inc. is engaged in developing solutions for cancer screening, risk stratification, minimal residual disease detection, biomarker subtyping, treatment monitoring, and recurrence tracking. The company's work is centered on improving outcomes through early intervention and personalized treatment strategies. The focus on early detection aligns with efforts to reduce cancer mortality rates and improve patient survival rates globally. Grail Inc. operates with a technology-driven approach to revolutionize cancer care through innovative diagnostic tools and methodologies. Grail is one of the most popular companies on Eulerpool.

ROA Details

Understanding Grail's Return on Assets (ROA)

Grail's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Grail's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Grail's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Grail’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Grail stock

Return on Assets (ROA) of Grail is -13.97 % in 2025.

Return on Assets (ROA) of Grail changed from -67.94 % to -13.97 %, representing a -79.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Grail since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Grail with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Grail

All Key Metrics — Grail